B. Pau

发表

Peptides derived from the two regulatory domains of p53 are recognized by two p53-activating antibodies

Claude Granier, Françoise Roquet, J. Portefaix, 2003, Peptides.

Impact of RNA degradation on gene expression profiles: assessment of different methods to reliably determine RNA quality.

P. Mazière, M. Ychou, V. Copois, 2007, Journal of biotechnology.

Time-course of cardiac troponin I release from isolated perfused rat hearts during hypoxia/reoxygenation and ischemia/reperfusion.

J. E. de la Coussaye, B. Pau, M. Dauzat, 1999, Clinica chimica acta; international journal of clinical chemistry.

Circulating cardiac troponin I in severe congestive heart failure.

B. Pau, E. Missov, C. Calzolari, 1997, Circulation.

Cardiac troponin I in the diagnosis of myocardial injury and infarction.

E Ambach, P. Mair, J. Mair, 1996, Clinica chimica acta; international journal of clinical chemistry.

Release kinetics of serum cardiac troponin I in ischemic myocardial injury.

B. Pau, P. Fabbro-Péray, B. Ledermann, 1996, Clinical biochemistry.

Synthesis of new hydrophilic microspheres: Optimized carriers for microparticle‐enhanced nephelometric immunoassays

B. Pau, J. Marchand, P. Varcin, 1992, Biopolymers.

ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan‐treated metastases

Y. Pommier, M. Ychou, V. Copois, 2004, International journal of cancer.

Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis

M. Wainberg, A. Garcel, Noëlie Campos, 2015, Retrovirology.

Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan.

Franck Molina, Andrew Kramar, Pierre Martineau, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cardiac troponin I in patients with hematologic malignancies

B. Pau, F. Leclercq, J. Davy, 1997, Coronary artery disease.

Epitope mapping and binding analysis of insulin-specific monoclonal antibodies using a biosensor approach.

C. Granier, B. Pau, S. Allauzen, 1995, Journal of immunological methods.

Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.

P. Vermersch, J. Touchon, R. Sabatier, 1999, Neuroreport.

Production and characterization of monoclonal antibodies against human thyroglobulin.

B. Pau, J. Bastide, M. Cot, 1985, Hybridoma.

Systematic Exploration of the Antigen Binding Activity of Synthetic Peptides Isolated from the Variable Regions of Immunoglobulins*

D. Laune, F. Molina, C. Granier, 1997, The Journal of Biological Chemistry.

Oxaliplatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA

G. Kroemer, B. Pau, Laure Crabbe, 2004, Oncogene.

Assay for measurement of intact B-type natriuretic peptide prohormone in blood.

C. Granier, B. Pau, J. Cristol, 2006, Clinical chemistry.

Characterization of a monoclonal antibody produced in an attempt to mimic the active site of HIV aspartyl protease using haptens based on inhibitor models.

B. Pau, P. Jouin, J. Mani, 1994, Journal of immunological methods.

A peptide mimetic of an anti-CD4 monoclonal antibody by rational design.

A. Rees, D. Laune, C. Granier, 2003, Biochemical and biophysical research communications.

An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan.

B. Pau, J. Bastide, R. Cherniak, 1990, Research in immunology.

M. del Río, S. Kaveri, M. Kazatchkine, 1993, Journal of autoimmunity.

of the Renin System

J. Ménard, P. Gros, B. Pau, 1984 .

JLP5B9: new monoclonal antibody against polysialylated neural cell adhesion molecule is of value in phenotyping lung cancer.

P. Demoly, J. Laurent, B. Pau, 2000, Journal of immunological methods.

New immunoassay for the mapping of neurofibrillary degeneration in Alzheimer's disease using two monoclonal antibodies against human paired helical filament tau proteins

A. Delacourte, A. Wattez, B. Pau, 1995, Neuroscience Letters.

Whole blood capcellia CD4/CD8 immunoassay for enumeration of CD4+ and CD8+ peripheral T lymphocytes.

B. Pau, J. Reynes, M. Laprade, 1999, Clinical chemistry.

High specific cytotoxicity of antibody-toxin hybrid molecules (immunotoxins) for target cells

P. Casellas, P. Gros, B. Pau, 1980 .

Immunotoxins: Hybrid Molecules Combining High Specificity and Potent Cytotoxicity

Dominique, P. Casellas, P. Gros, 1982, Immunological reviews.

Two-site direct immunoassay specific for active renin.

D. Hartmann, B. Pau, P. Corvol, 1992, Clinical chemistry.

Thyroglobulin IRMA Pasteur immunoassay: sensitivity of the assay and interference from thyroglobulin autoantibodies.

P. Marquet, B. Pau, C. Calzolari, 1997, Clinical chemistry.

Release of muscle proteins after downhill running in male and female subjects

J. Mair, B. Pau, B. Puschendorf, 2001, Scandinavian journal of medicine & science in sports.

Process for titrating C-peptide

B. Pau, C. Larue, J. Mani, 1997 .

Monoclonal antibody against a gill Rickettsiales-like organism of Pecten maximus (Bivalvia): application to indirect immunofluorescence diagnosis

B. Pau, V. Boulo, E. Mialhe, 1992 .

The Natural Mutation Y248C of Human Angiotensinogen Leads to Abnormal Glycosylation and Altered Immunological Recognition of the Protein (*)

X. Jeunemaître, B. Pau, P. Cohen, 1996, The Journal of Biological Chemistry.

Characterization of monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells.

B. Pau, H. Rochefort, M. García, 1985, Cancer research.

Electroimmunoassay of human serum lipoproteins containing Apo A-I by monoclonal antibodies.

B. Pau, J. Polonovski, H. Robin, 1988, Clinica chimica acta; international journal of clinical chemistry.

Monoclonal antibodies to human apolipoprotein A-I: characterization and application as structural probes for apolipoprotein A-I and high density lipoprotein.

B. Pau, J. Polonovski, H. Robin, 1987, Biochimica et biophysica acta.

High circulating levels of cardiac troponin I in human congestive heart failure

B. Pau, E. Missov, C. Calzolari, 1996 .

Critical residues of epitopes recognized by several anti-p53 monoclonal antibodies correspond to key residues of p53 involved in interactions with the mdm2 protein.

T. Soussi, J. Portefaix, C. Granier, 2000, Journal of immunological methods.

Imaging of myocardial infarction in dogs and humans using monoclonal antibodies specific for human myosin heavy chains.

B. Pau, J. Chevalier, C. Larue, 1991, Journal of the American College of Cardiology.

Cardiac-Specific lmmunoenzymometric Assay of Troponin I in the Early Phase of Acute Myocardial Infarction

B. Pau, F. Leclercq, J. Bertinchant, 2004 .

Levels of ventricular myosin fragments in human sera after myocardial infarction, determined with monoclonal antibodies to myosin heavy chains

J. Léger, R. Roncucci, B. Pau, 1985, European journal of clinical investigation.

Immunoanalysis of human insulin using monoclonal antibodies reveals antigenicity of evolutionarily conserved residues.

F. Molina, C. Granier, B. Pau, 1995, Molecular immunology.

Direct, simplified, and sensitive assay of angiotensin II in plasma extracts performed with a high-affinity monoclonal antibody.

B. Pau, P. Corvol, J. Fehrentz, 1992, Clinical chemistry.

Analysis of inactive renin by renin profragment monoclonal antibodies

B. Pau, R. Seyer, P. Corvol, 1986, FEBS letters.

Use of monoclonal antibodies to human apo A-I in the determination of antigenic sites present on HDL surface.

B. Pau, J. Polonovski, H. Robin, 1987, Advances in experimental medicine and biology.

Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction.

B. Pau, F. Leclercq, C. Larue, 1993, Clinical chemistry.

Troponin I immunoenzymometric assays for detection of muscle damage applied to monitoring a triathlon.

P. Gros, B. Pau, A. Orsetti, 1996, Clinical chemistry.

Heterogeneity in the conformation of apo A-I on the surface of HDL particles.

B. Pau, J. Polonovski, F. Paolucci, 1988, Advances in experimental medicine and biology.

Antibodies designed to mimic the active site of HIV aspartyl protease

B. Pau, Chuan-fa Liu, N. Galéotti, 1992 .

Selective recognition of M235T angiotensinogen variants and their determination in human plasma by monoclonal antibody-based immunoanalysis.

J. Ménard, X. Jeunemaître, B. Pau, 1996, The Journal of clinical endocrinology and metabolism.

Accurate topological comparison of two recombinant human growth hormones by optical surface plasmon resonance.

P Ferrara, P. Ferrara, B. Pau, 1997, Analytical biochemistry.

New monoclonal antibodies directed against the propart segment of human prorenin as a tool for the exploration of prorenin conformation.

J. Portefaix, B. Pau, P. Cohen, 1995, Journal of immunological methods.

New antigenic clusters on human thyroglobulin defined by an expanded panel of monoclonal antibodies.

B. Pau, V. Hanin, M. Bastide, 1992, Immunology letters.

Novel anti-digoxin monoclonal antibodies with different binding specificities for digoxin metabolites and other glycosides.

B. Pau, J. Bastide, D. Wahyono, 1990, Hybridoma.

Production and characterization of monoclonal antibodies to human growth hormone.

B. Pau, F. Paolucci, E. Hervaud, 1987, Hybridoma.

Measurement of active renin by the 4G1 anti-human renin monoclonal antibody.

J. Ménard, B. Pau, P. Corvol, 1987, Clinical and experimental hypertension. Part A, Theory and practice.

Production and partial characterization of monoclonal antibodies against 3,3',5-triiodo-L-thyronine.

B. Pau, J. Marchand, D. Simon, 1987, Hybridoma.

Production and partial characterization of anti-Candida monoclonal antibodies.

B. Pau, J. Bastide, T. Chardès, 1986, Annales de l'Institut Pasteur. Immunologie.

Monoclonal antibody against human renin.

J. Ménard, B. Pau, F. Soubrier, 1981, The Journal of clinical endocrinology and metabolism.

Highly sensitive immunoassay for direct diagnosis of viral hemorrhagic septicemia which uses antinucleocapsid monoclonal antibodies

B. Pau, B. Romestand, P. de Kinkelin, 1992, Journal of clinical microbiology.

Determination of cardiac troponin I forms in the blood of patients with unstable angina pectoris.

C. Granier, B. Pau, C. Larue, 2002, Clinical biochemistry.

Peptide specificity of high-titer anti-glutamic acid decarboxylase (GAD)65 autoantibodies.

P. van Endert, C. Granier, B. Pau, 1998, Immunology letters.

Efficient therapy for refractory Pompe disease by mannose 6‐phosphate analogue grafting on acid &agr;‐glucosidase

B. Pau, M. Maynadier, Marcel Garcia, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Skeletal troponin-I release in orthopedic and soft tissue injuries

E. K. Alpar, B. Pau, M. Laprade, 2001, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

Systematic mapping of regions of human cardiac troponin I involved in binding to cardiac troponin C: N‐ and C‐terminal low affinity contributing regions

C. Granier, B. Pau, M. Pugnière, 2000, FEBS letters.

Thyroid Peroxidase Autoantibodies Obtained from Random Single Chain Fv Libraries Contain the Same Heavy/Light Chain Combinations as Occur in Vivo.

B. Pau, D. Bresson, J. Mani, 2001, Endocrinology.

Human Anti-Thyroid Peroxidase Single-Chain Fragment Variable of Ig Isolated from a Combinatorial Library Assembled In-Cell: Insights into the In Vivo Situation1

C. Granier, B. Pau, D. Bresson, 2000, The Journal of Immunology.

Analysis of the V genes coding for a monospecific human antibody to myosin and functional expression of single chain Fv fragments

B. Pau, M. Biard-Piechaczyk, G. Clofent-Sanchez, 1999, FEBS letters.

In-cell assembly of scFv from human thyroid-infiltrating B cells.

B. Pau, I. Navarro-Teulon, M. Biard-Piechaczyk, 1997, BioTechniques.

Direct immunometric assay of active renin in human plasma.

J. Ménard, R. Roncucci, B. Pau, 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells

P. Casellas, P. Gros, B. Pau, 1981, Nature.

REPLACEMENT OF THE B CHAIN OF RICIN WITH SPECIFIC CONVENTIONAL OR MONOCLONAL ANTIBODIES

P. Casellas, P. Gros, B. Pau, 1981 .

Antigenic domains on the human thyroglobulin molecule recognized by autoantibodies in patients' sera and by natural autoantibodies isolated from the sera of healthy subjects.

B. Pau, J. Bastide, M. Bastide, 1987, Clinical immunology and immunopathology.

Epitope localization of monoclonal antibodies used in human troponin I immunoenzymometric assay.

C. Granier, B. Pau, C. Calzolari, 1997, Hybridoma.

Distribution of the Mr 52,000 estrogen-regulated protein in benign breast diseases and other tissues by immunohistochemistry.

B. Pau, M. García, J. Domergue, 1986, Cancer research.

Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma

C. Auffray, Y. Pommier, M. Ychou, 2002, FEBS letters.

Altered expression of cell proliferation-related and interferon-stimulated genes in colon cancer cells resistant to SN38

V. Denis, V. Copois, C. Fraslon, 2008, Cancer biology & therapy.

Ultrasensitive dosing method for the cardiac troponin i

B. Pau, C. Calzolari, O. Flecheux, 1995 .

Immunoradiometric assay of myosin heavy chain fragments in plasma for investigation of myocardial infarction.

B. Pau, C. Larue, C. Calzolari, 1991, Clinical chemistry.

Synthetic Peptides Derived from the Variable Regions of an Anti-CD4 Monoclonal Antibody Bind to CD4 and Inhibit HIV-1 Promoter Activation in Virus-infected Cells*

D. Laune, C. Granier, B. Pau, 1999, The Journal of Biological Chemistry.

Detection of antithyroglobulin autoantibodies with defined epitopic specificity by a microparticle-enhanced nephelometric immunoassay.

B. Pau, P. Montagne, M. Cuillière, 1992, Clinical chemistry.

Binding specificity of monoclonal antibody AD2: influence of the phosphorylation state of tau.

C. Granier, F. Roquet, B. Pau, 2000, Brain research. Molecular brain research.

Monoclonal antibodies to low density lipoprotein used for the study of low- and very-low-density lipoproteins, in "ELISA" and immunoprecipitation technics.

B. Pau, S. Goldstein, S. Salmon, 1984, Biochemical and Biophysical Research Communications - BBRC.

Levels of myosin heavy chain fragment in patients with tissue damage.

E. K. Alpar, B. Pau, M. Laprade, 2001, Archives of medical research.

Novel ImmunoradiometricAssay of Thyroglobulinin Serum with Use of MonoclonalAntibodies Selected for Lack of Cross-Reactivitywith Autoantibodies

B. Pau, Plechaczyk, 2004 .

NovelImmunoradiometric Assayof Thyroglobulin inSerumwithUseof Monoclonal Antibodies Selectedfor Lackof Cross-Reactivity withAutoantibodies

B. Pau, 1989 .

A new approach for clinical biological assay comparison and standardization: application of principal component analysis to a multicenter study of twenty-one carcinoembryonic antigen immunoassay kits.

B. Thirion, R. Sabatier, B. Pau, 1999, Clinical chemistry.

The type‐1 repeats of thyroglobulin regulate thyroglobulin degradation and T3, T4 release in thyrocytes

F. Molina, C. Granier, B. Pau, 1996, FEBS letters.

Characterization of the type-1 repeat from thyroglobulin, a cysteine-rich module found in proteins from different families.

F. Molina, C. Granier, B. Pau, 1996, European journal of biochemistry.

Autoimmunity to human thyroglobulin. Respective epitopic specificity patterns of anti-human thyroglobulin autoantibodies in patients with Sjögren's syndrome and patients with Hashimoto's thyroiditis.

B. Pau, M. Bastide, M. Bouanani, 2010, Arthritis and rheumatism.

Human cardiac troponin I: precise identification of antigenic epitopes and prediction of secondary structure.

D. Laune, C. Granier, B. Pau, 1998, Clinical chemistry.

Pharmacoproteomic approach to the study of drug mode of action, toxicity, and resistance: applications in diabetes and cancer

Franck Molina, Laurence Molina, F. Molina, 2004, Fundamental & clinical pharmacology.

Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.

G. Reach, B. Pau, A. Ktorza, 2004, American journal of physiology. Endocrinology and metabolism.

Pharmacological modulation of LMNA SRSF1-dependent splicing abrogates diet-induced obesity in mice

Carine, D. Scherrer, J. Tazi, 2017, International Journal of Obesity.

The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family

G. Kroemer, P. Boya, B. Pau, 2003, Oncogene.

Improved performances of spot multiple peptide synthesis.

D. Laune, F. Molina, C. Granier, 1996, Peptide research.

Significance of the recognition of certain antigenic regions on the human thyroglobulin molecule by natural autoantibodies from healthy subjects.

B. Pau, M. Bastide, M. Bouanani, 1989, Journal of immunology.

Novel immunoradiometric assay of thyroglobulin in serum with use of monoclonal antibodies selected for lack of cross-reactivity with autoantibodies.

B. Pau, J. Bastide, L. Baldet, 1989, Clinical chemistry.

Two-Site ImmunoenzymometricAssay for the 52-kDa Cathepsin D in Cytosolsof Breast Cancer Tissues

B. Pau, Marcel Garcia, Gilles, 2004 .

Selection and Characterization of Monoclonal Antibodies Directed against Human Chorionic Gonadotropin

P. Gros, B. Pau, J. Bastide, 1984 .

Idiotypic restriction of murine monoclonal antibodies to a defined antigenic region of human thyroglobulin.

B. Pau, M. del Rio, M. Bastide, 1995, Immunological investigations.

Synthetic peptides derived from human glutamic acid decarboxylase (GAD) and their use in IDDM diagnosis

J. Portefaix, C. Granier, B. Pau, 1995 .

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.

I. Christensen, B. Rasmussen, C. Rose, 1989, Cancer research.

Immunohistochemical detection of the estrogen-regulated 52,000 mol wt protein in primary breast cancers but not in normal breast and uterus.

B. Pau, H. Rochefort, M. García, 1984, The Journal of clinical endocrinology and metabolism.

Detection of anti-p53 antibodies by ELISA using p53 synthetic or phage-displayed peptides.

Claude Granier, Richard Perham, E. Crapez, 2002, Journal of immunological methods.

Analysis of the individual contributions of immunoglobulin heavy and light chains to the binding of antigen using cell transfection and plasmon resonance analysis.

B. Pau, I. Navarro-Teulon, M. Biard-Piechaczyk, 1996, Journal of immunological methods.

Expression in Escherichia coli of soluble and M13 phage-displayed forms of a single-chain antibody fragment specific for digoxin: assessment in a novel drug immunoassay.

B. Pau, I. Navarro-Teulon, M. Biard-Piechaczyk, 1995, Immunotechnology : an international journal of immunological engineering.

Affinity for the cognate monoclonal antibody of synthetic peptides derived from selection by phage display. Role of sequences flanking thebinding motif.

D. Laune, C. Granier, B. Pau, 2000, European journal of biochemistry.

AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease.

A. Delacourte, M. Goedert, B. Pau, 1996, Brain research. Molecular brain research.

Production and characterization of highly specific anti-methotrexate monoclonal antibodies.

B. Pau, J. Bastide, M. Cot, 1987, Hybridoma.

Comparison of different immunoenzymatic methods for the determination of the fine specificity and affinity constants of polyclonal antibodies against pseudopeptide haptens.

B. Pau, P. Jouin, V. Hanin, 1997, Immunological investigations.

New monoclonal antibodies as probes for human cardiac troponin I: epitopic analysis with synthetic peptides.

B. Pau, C. Larue, C. Calzolari, 1992, Molecular immunology.

alpha2-Macroglobulin, the main serum antiprotease, binds beta2-microglobulin, the light chain of the class I major histocompatibility complex, which is involved in human disease.

D. Laune, C. Granier, B. Pau, 2000, Clinical science.

Two-SiteImmunoassay of Recombinant HirudinBasedonTwo Monoclonal Antibodies

M. Maftouh, B. Pau, C. Picard, 1994 .

Highly Specific Radioimmunoassay for Digoxin Using a Monoclonal Antibody Selected for Lack of Interference by Digoxin‐Like Immunoreactive Substances in Cord Blood Sera

B. Pau, J. Bastide, J. Grenier, 1991, Therapeutic Drug Monitoring.

Dissection of an antibody paratope into peptides discloses the idiotope recognized by the cognate anti-idiotypic antibody.

D. Laune, F. Molina, C. Granier, 2000, Journal of immunological methods.

An efficient immunization protocol for production of monoclonal antibodies against soluble human insulin.

B. Pau, S. Allauzen, M. Bastide, 1994, Immunology letters.

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.

I. Christensen, B. Rasmussen, B. Pau, 1989, Cancer research.

Microparticle‐enhanced nephelometric immunoassay for human C‐reactive protein

B. Pau, P. Varcin, P. Montagne, 1992, Journal of clinical laboratory analysis.

Two-site immunoenzymometric assay for the 52-kDa cathepsin D in cytosols of breast cancer tissues.

B. Pau, H. Rochefort, G. Freiss, 1989, Clinical chemistry.

Gene expression signature for the prediction of FOLFIRI response in advanced colorectal cancer patients

Caroline, M. Ychou, V. Copois, 2010 .

Reliability and feasibility of pregnancy home-use tests: laboratory validation and diagnostic evaluation by 638 volunteers.

B. Pau, C. Casellas, B Pau, 1993, Clinical chemistry.

Highly sensitive immunoradiometric assay for serum thyroglobulin with minimal interference from autoantibodies.

D. Hartmann, P. Marquet, B. Bridgi, 1996, Clinical chemistry.

Polyacrylic microspheres as a solid phase for microparticle enhanced nephelometric immunoassay (NEPHELIA (R)) of transferrin.

B. Pau, J. Marchand, P. Varcin, 1991, Journal of immunoassay.

CD4 masking during human immunodeficiency virus type 1 infection, quantified on peripheral blood lymphocytes, is a potential marker of disease progression.

P. Gros, B. Pau, J. Reynes, 1996, The Journal of infectious diseases.

Evidence for a restricted idiotypic and epitopic specificity of anti‐thyroglobulin autoantibodies in patients with autoimmune thyroiditis

M. Kazatchkine, B. Pau, G. Dietrich, 1991, European journal of immunology.

Conserved natural humoral immunity to thyroglobulin in patients with multiple myeloma

B. Klein, R. Bataille, B. Pau, 1992, British journal of haematology.

A major human thyroglobulin epitope defined with monoclonal antibodies is mainly recognized by human autoantibodies

B. Pau, Y. Malthiéry, E. Zanelli, 1992, European journal of immunology.

The PGK epitope of human thyroglobulin: A molecular marker of alternatively spliced thyroglobulin molecules?

F. Molina, C. Granier, B. Pau, 1997, Letters in Peptide Science.

Detectionof Antithyroglobulin Autoantibodies withDefinedEpitopicSpecificityby a

B. Pau, P. Montague, M. Bouanani, 1992 .

Efficient amplification and direct sequencing of mouse variable regions from any immunoglobulin gene family

B. Pau, T. Chardès, S. Villard, 1999, FEBS letters.

Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters.

T. Maudelonde, B. Pau, H. Rochefort, 1988, Cancer research.

A two-site immunoenzymometric assay of 52-kDa pro-cathepsin D, and its use in human breast diseases.

B. Pau, H. Rochefort, G. Freiss, 1989, Clinical chemistry.

Peptide Models of Immunological Recognition: Paratope Dissection by Multiple Peptide Synthesis

D. Laune, C. Granier, B. Pau, 1998, Clinical chemistry and laboratory medicine.

Molecular characterization of the epitope recognized by mAb 19 on the human insulin molecule

F. Molina, C. Granier, B. Pau, 1995 .

Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.

G. Reach, B. Pau, A. Ktorza, 2004, American journal of physiology. Endocrinology and metabolism.

Human single-chain Fv fragments from a combinatorial library using the loxP-Cre recombination system.

M. del Río, B. Pau, M. Biard-Piechaczyk, 1999, Human antibodies.

[Pharmaco-proteomic analysis: application of proteomic analysis to the discovery and development of new drugs].

J. Garin, B. Pau, P. Petit, 2002, Journal de la Societe de biologie.